ACHC übertreffen die 25 der letzten 39Schätzungen.
64%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate forQ4 25(Revenue/ EPS)
$817.68M
/
$0.20
Implizierte Änderung vonQ3 25(Revenue/ EPS)
-3.98%
/
-72.22%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+5.61%
/
-68.75%
Acadia Healthcare Company, Inc. earnings per share and revenue
On 05. Nov. 2025, ACHC reported earnings of 0.72 USD per share (EPS) for Q3 25, beating the estimate of 0.68 USD, resulting in a 5.25% surprise. Revenue reached 851.57 million, compared to an expected 862.65 million, with a -1.28% difference. The market reacted with a -2.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of 0.20 USD, with revenue projected to reach 817.68 million USD, implying an decrease of -72.22% EPS, and decrease of -3.98% in Revenue from the last quarter.
FAQ
What were Acadia Healthcare Company, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Acadia Healthcare Company, Inc. reported EPS of $0.72, beating estimates by 5.25%, and revenue of $851.57M, -1.28% below expectations.
How did the market react to Acadia Healthcare Company, Inc.'s Q3 2025 earnings?
The stock price moved down -2.03%, changed from $20.68 before the earnings release to $20.26 the day after.
When is Acadia Healthcare Company, Inc. expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Acadia Healthcare Company, Inc.'s next earnings report?
Based on 15
analysts, Acadia Healthcare Company, Inc. is expected to report EPS of $0.20 and revenue of $817.68M for Q4 2025.